These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36996503)

  • 1. The effects of topical oxymetazoline on eyelid position, eye redness, and patient-reported eye appearance: A randomized controlled trial.
    Shoji MK; Markatia Z; Ameli K; Bayaraa M; Clauss KD; Ugradar S; Lee WW
    J Plast Reconstr Aesthet Surg; 2023 May; 80():66-74. PubMed ID: 36996503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes to Eye Whiteness and Eyelid/Brow Position With Topical Oxymetazoline in Aesthetic Patients.
    Ugradar S; Kim JS; Trost N; Parunakian E; Zimmerman E; Ameli K; Shoji MK; Lee WW
    Aesthet Surg J; 2022 May; 42(6):582-589. PubMed ID: 34962512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Oxymetazoline Hydrochloride, 0.1%, Solution Administration With Visual Field in Acquired Ptosis: A Pooled Analysis of 2 Randomized Clinical Trials.
    Slonim CB; Foster S; Jaros M; Kannarr SR; Korenfeld MS; Smyth-Medina R; Wirta DL
    JAMA Ophthalmol; 2020 Nov; 138(11):1168-1175. PubMed ID: 33001144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Treatment of Myasthenic Ptosis with Topical Ocular Oxymetazoline.
    Cooper J; Yang D
    Optom Vis Sci; 2021 Nov; 98(11):1317-1320. PubMed ID: 34510144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results.
    Bacharach J; Wirta DL; Smyth-Medina R; Korenfeld MS; Kannarr SR; Foster S; J Jaros M; Slonim CB
    Clin Ophthalmol; 2021; 15():2743-2751. PubMed ID: 34211263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Upper Aging Blepharoplasty on Upper and Lower Eyelid Position.
    Park J; Choi B; Baek S
    J Craniofac Surg; 2018 May; 29(3):747-750. PubMed ID: 29420375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative Significance of Lower Eyelid Positions in Levator Advancement to Prevent Overcorrection.
    Kim J; Yoon S; Lee H; Lee H; Baek S
    J Craniofac Surg; 2022 Jul-Aug 01; 33(5):1563-1565. PubMed ID: 34743157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Lower Eyelid Positions After Blepharoplasty and Levator Advancement Surgery.
    Kim J; Yoon S; Lee H; Lee H; Baek S
    J Craniofac Surg; 2022 Sep; 33(6):e626-e628. PubMed ID: 35882245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aesthetic Changes of Brow-Eyelid Continuum After Correction of Moderate-Severe Blepharoptosis with Conjoint Fascial Sheath Suspension.
    Fan X; Hao DY; Cao J; Cang ZQ; Cui JB; He YX; Liu CH; Peng P; Song BQ
    Aesthetic Plast Surg; 2022 Dec; 46(6):2825-2832. PubMed ID: 35441847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upper Eyelid and Pupillary Effects of Topical Dilute Epinephrine.
    Garcia GA; Ngai P; Vemuri S; Tao JP
    Ophthalmic Plast Reconstr Surg; 2017; 33(2):106-111. PubMed ID: 26882061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship Between Eyebrow and Eyelid Position in Patients With Ptosis, Dermatochalasis and Controls.
    Sinha KR; Al Shaker S; Yeganeh A; Moreno T; Rootman DB
    Ophthalmic Plast Reconstr Surg; 2019; 35(1):85-90. PubMed ID: 30124610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical Trials.
    Wirta DL; Korenfeld MS; Foster S; Smyth-Medina R; Bacharach J; Kannarr SR; Jaros MJ; Slonim CB
    Clin Ophthalmol; 2021; 15():4035-4048. PubMed ID: 34675472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palpebral position interdependence in blepharoptosis: comparison of the effect of instillation of 10% phenylephrine drop and digital lifting.
    Pereira IC; Matayoshi S
    Arq Bras Oftalmol; 2014; 77(6):377-81. PubMed ID: 25627185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial.
    Kircik LH; DuBois J; Draelos ZD; Werschler P; Grande K; Cook-Bolden FE; Weng E; Berk DR; Ahluwalia G
    J Drugs Dermatol; 2018 Jan; 17(1):97-105. PubMed ID: 29320594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL Trial.
    Baumann L; Goldberg DJ; Stein Gold L; Tanghetti EA; Lain E; Kaufman J; Weng E; Berk DR; Ahluwalia G
    J Drugs Dermatol; 2018 Mar; 17(3):290-298. PubMed ID: 29537447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Eyelid Position and Facial Nerve Palsy With Unresolved Weakness.
    Sinha KR; Rootman DB; Azizzadeh B; Goldberg RA
    JAMA Facial Plast Surg; 2016 Sep; 18(5):379-84. PubMed ID: 27311069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of luminous intensity on the eyelid aperture and measurement of the margin reflex distance.
    Lima Lang MP; Marinho DR; Procianoy F
    Orbit; 2022 Jun; 41(3):311-314. PubMed ID: 33663331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of topical Phenylephrine on the upper eyelid crease position.
    Queirós TSM; Won-Kim HR; Sales-Sanz A; Sales-Sanz M
    Acta Ophthalmol; 2020 Dec; 98(8):e1024-e1027. PubMed ID: 32378788
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.